Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION

(2018) Nancy Luo et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart rate and its reduction in chronic heart failure and beyond

(2017) Aleksandra Nikolovska Vukadinović et al.   EUROPEAN JOURNAL OF HEART FAILURE

Long-term treatment with ivabradine over 12 months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations

(2017) C. Zugck et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study

(2017) D. Zachariah et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study

(2017) Josef Stehlik et al.   JOURNAL OF CARDIAC FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials

(2016) Ewa A. Jankowska et al.   EUROPEAN JOURNAL OF HEART FAILURE

Utility of Patient-Reported Outcome Instruments in Heart Failure

(2016) Anita A. Kelkar et al.   JACC-Heart Failure

Patient-Reported Outcomes in Chronic Heart Failure

(2016) Mitchell A. Psotka et al.   JACC-Heart Failure

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status

(2013) John S. Rumsfeld et al.   CIRCULATION

New Therapeutic Targets in Cardiology

(2013) François Roubille et al.   CIRCULATION

Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

(2013) Jan-Christian Reil et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

(2012) Michael Böhm et al.   Clinical Research in Cardiology

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

(2012) Karl Swedberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ivabradine Improves All Aspects of Quality of Life Assessed with the 36-Item Short Form Health Survey in Subjects with Chronic Ischemic Heart Disease Compared with Beta-Blockers

(2012) G. Riccioni et al.   PHARMACOLOGY

Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure

(2011) Kathryn E. Flynn et al.   AMERICAN HEART JOURNAL

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study

(2011) Inger Ekman et al.   EUROPEAN HEART JOURNAL

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy

(2011) Jean-Claude Tardif et al.   EUROPEAN HEART JOURNAL

Vascular Pathophysiology in Response to Increased Heart Rate

(2010) Florian Custodis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

(2010) Michael Böhm et al.   LANCET

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

(2009) Stefan D. Anker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers

(2008) Genevieve Flannery et al.   AMERICAN JOURNAL OF CARDIOLOGY